摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-氟苯基)-3-苯丙酸 | 362-86-7

中文名称
3-(4-氟苯基)-3-苯丙酸
中文别名
——
英文名称
3-(4-fluorophenyl)-3-phenylpropanoic acid
英文别名
——
3-(4-氟苯基)-3-苯丙酸化学式
CAS
362-86-7
化学式
C15H13FO2
mdl
——
分子量
244.265
InChiKey
NKBOILGAWSETPR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2916399090

SDS

SDS:17e39adcea7fbc132f463fa0912d9963
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    不饱和酰卤的反应-IV 1:双官能肉桂酰氯对单卤代苯的竞争性弗里德-克拉斯酰化和烷基化
    摘要:
    已经研究了氯化铝催化的单卤代苯与肉桂酰氯的酰化和烷基化。在严格均质的条件下,相对于酰化而言,烷基化越来越受到关注,因为酰化是沿着该系列的主要反应:苯<氟苯<溴代苯<氯代苯。更改为非均相条件(使用CS 2作为稀释剂的过量催化剂)保留了该顺序,但伯烷基化相对增强。在均相反应中加入硝基苯比烷基化更能抑制烷基化。
    DOI:
    10.1016/0040-4020(78)88113-7
  • 作为产物:
    描述:
    Alpha-氯-Alpha-苯基-4-氟甲苯氢氧化钾 、 sodium hydride 、 sodium iodide 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 50.17h, 生成 3-(4-氟苯基)-3-苯丙酸
    参考文献:
    名称:
    Ring-substituted histaprodifen analogues as partial agonists for histamine H1 receptors: synthesis and structure–activity relationships
    摘要:
    Thirteen racemic benzene ring-substituted analogues of histaprodifen (8a; 2-[2-(3,3-diphenylpropyl)-1H-imidazol-4-yl]ethanamine), a novel lead for potent and selective histamine H-1-receptor agonists, have been prepared from substituted 4,4-diphenylbutyronitriles 5 via cyclization of the corresponding methyl butyrimidates 6 with 2-oxo-4-phthalimido-1-butyl acetate in liquid ammonia, followed by deprotection. Nitriles 5 were accessible by alkylation of either substituted diphenylmethanes with 3-bromopropionitrile or diethyl malonate with substituted 1-chloro-diphenylmethanes and subsequent standard reactions. The title compounds 8 displayed partial agonism on contractile H-1 receptors of the guinea-pig ileum (E-max = 2-98% relative to histamine) and, compared with the endogenous agonist, were endowed with agonist potencies of 4-92%. The meta fluorinated (gc) and meta chlorinated (8f) analogues showed the highest relative potency in this series (95% confidence Limits 85-99% and 78-102%), but did not exceed the value of the lead 8a (99-124%). Compound 8c (2-[2-[3-(3-fluorophenyl)-3-phenylpropyl]-1H-imidazol-4-yl]ethanamine) was a partial agonist at contractile H-1 receptors of the guinea-pig aorta (relative potency 154% vs. 100% for histamine) and at relaxation-mediating endothelial H-1 receptors of the rat aorta (relative potency 556% vs. 100% for histamine) and matched with the functional behaviour of 8a. Agonism observed for each compound was sensitive to blockade by the selective H-1-receptor antagonist mepyramine (pA(2) approximate to 9 (guinea-pig) and pA(2) approximate to 8 (rat aorta)). All histaprodifen analogues 8 stimulated neither histaminergic H-2/H-3, nor cholinergic M-3 receptors. They displayed only low to moderate affinity for these sites (H-2: pD'(2), < 5; H-3/M-3: pA(2) < 6). With regard to the substitution pattern on the benzene ring, there was no correlation between the histaprodifen series and the corresponding derivatives of another selective H-1-receptor agonist, viz. 2-phenylhistamine. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
    DOI:
    10.1016/s0223-5234(00)00105-7
点击查看最新优质反应信息

文献信息

  • Pd(II)/Bipyridine-Catalyzed Conjugate Addition of Arylboronic Acids to α,β-Unsaturated Carboxylic Acids. Synthesis of β-Quaternary Carbons Substituted Carboxylic Acids
    作者:Rui Liu、Zhenyu Yang、Yuxin Ni、Kaixuan Song、Kai Shen、Shaohui Lin、Qinmin Pan
    DOI:10.1021/acs.joc.7b01248
    日期:2017.8.4
    Pd(II)/bipyridine-catalyzed conjugate addition of arylboronic acids to α,β-unsaturated carboxylic acids (including β,β-disubstituted acrylic acids) was developed and optimized, which provided a mild and convenient method for the highly challenging synthesis of β-quaternary carbons substituted carboxylic acids.
    开发并优化了Pd(II)/联吡啶催化的芳基硼酸向α,β-不饱和羧酸(包括β,β-二取代的丙烯酸)的共轭加成反应,为高难度的β合成提供了温和而便捷的方法-季碳取代的羧酸。
  • Acylguanidines as Bioisosteres of Guanidines: <i>N</i><sup>G</sup>-Acylated Imidazolylpropylguanidines, a New Class of Histamine H<sub>2</sub> Receptor Agonists
    作者:Prasanta Ghorai、Anja Kraus、Max Keller、Carsten Götte、Patrick Igel、Erich Schneider、David Schnell、Günther Bernhardt、Stefan Dove、Manfred Zabel、Sigurd Elz、Roland Seifert、Armin Buschauer
    DOI:10.1021/jm800841w
    日期:2008.11.27
    demonstrated by HPLC-MS, the acylguanidines (bioisosteres of the alkylguanidines) were absorbed from the gut of mice and detected in brain. In GTPase assays using recombinant receptors, acylguanidines were more potent at the guinea pig than at the human H2R. At the hH1R and hH3R, the compounds were weak to moderate antagonists or partial agonists. Moreover, potent partial hH4R agonists were identified. Receptor
    N1-芳基(杂芳基)烷基-N2- [3-(1H-咪唑-4-基)丙基]胍是有效的组胺H2受体(H2R)激动剂,但由于缺乏口服生物利用度和CNS渗透性而削弱了它们的适用性。为了改善药代动力学,我们在胍基部分附近引入了羰基而不是亚甲基,从而将新型H2R激动剂的碱性降低了4-5个数量级。一些具有一个苯环的酰基胍比其二芳基类似物甚至更有效。如通过HPLC-MS证明的,酰基胍(烷基胍的生物等排体)从小鼠的肠中吸收并在脑中检测到。在使用重组受体的GTPase检测中,豚鼠的酰基胍比人的H2R更有力。在hH1R和hH3R处,这些化合物对中度拮抗剂或部分激动剂均弱。而且,确定了有效的部分hH4R激动剂。受体亚型的选择性取决于咪唑基丙基胍基团(特权结构),为包括强效H4R激动剂在内的独特药理学手段开辟了道路。
  • Cationic Pd(II)/bipyridine-catalyzed conjugate addition of arylboronic acids to α,β-unsaturated carboxylic acids in aqueous media
    作者:Yuxin Ni、Kaixuan Song、Kai Shen、Zhenyu Yang、Rui Liu、Shaohui Lin、Qinmin Pan
    DOI:10.1016/j.tetlet.2018.02.013
    日期:2018.3
    An in-situ generated cationic Pd(II)/bipyridine-catalyzed conjugate addition of arylboronic acids to α,β-unsaturated carboxylic acids in water was developed and optimized. For most substrates, nearly quantitative yields were given, and the products can be purified by simple washing without column chromatography. The reaction can be scaled up to 1.0 g easily with excellent yields. Also the loading of
    开发并优化了芳基硼酸到水中α,β-不饱和羧酸的阳离子Pd(II)/联吡啶催化的阳离子共轭加成反应。对于大多数底物,给出了接近定量的收率,并且可以通过不经柱色谱的简单洗涤来纯化产物。可以轻松地将反应放大至1.0 g,并具有优异的收率。同样,催化剂的载量可以以适中的产率降低到1.0mol%,并且该反应提供了温和且容易的合成β-二取代的羧酸的方法。
  • Covalent organic framework supported Pd(II)‐catalyzed conjugate additions of arylboronic acids to α,β‐unsaturated carboxylic acids
    作者:Min Wen、Shujuan Lu、Chaogang Fan、Kai Shen、Shaohui Lin、Qinmin Pan
    DOI:10.1002/aoc.6263
    日期:2021.8
    A palladium(II)-coordinated covalent organic framework (Pd(II)@COF) was mechanochemically synthesized from [2,2′-bipyridine]-5,5′-diamine (Bpy) and 1,3,5-triformylphloroglucinol (Tp), which was demonstrated as a catalyst for conjugate addition of arylboronic acids to unreactive α,β-unsaturated carboxylic acids in aqueous media (water/acetone = 1:1). Modest to good yields were obtained for most substrates
    由[2,2'-联吡啶]-5,5'-二胺(Bpy)和1,3,5-三甲酰基间苯三酚(Tp)机械化学合成钯(II)配位的共价有机骨架(Pd(II)@COF) ),它被证明是芳基硼酸与非反应性 α,β-不饱和羧酸在水性介质 (水/丙酮 = 1:1) 中共轭加成的催化剂。大多数底物获得了中等至良好的产率,对催化剂可回收性的研究表明,多相催化剂在前 4 个循环中的产率大于 80%。这项研究拓宽了 COF 支持的催化的应用,并为 Pd(II) 催化提供了新的选择。
  • Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
    申请人:——
    公开号:US20040006081A1
    公开(公告)日:2004-01-08
    Compounds of formula (I), compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    式(I)的化合物,包含它们的组合物,制备它们的方法以及它们在医学疗法中的使用(例如在温血动物中调节CCR5受体活性)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐